相关实验视频

Updated: Jun 25, 2025

Noninvasive Sampling of Mucosal Lining Fluid for the Quantification of In Vivo Upper Airway Immune-mediator Levels

Noninvasive Sampling of Mucosal Lining Fluid for the Quantification of In Vivo Upper Airway Immune-mediator Levels

Published on: August 7, 2017

缺乏与阿托皮性皮肤炎严重程度和形态与喘发作和控制的关联

Savanna I Vidal¹, Jonathan I Silverberg²

¹Department of Dermatology, George Washington University School of Medicine and Health Sciences, Suite 2B-425, 2150 Pennsylvania Avenue NW, Washington, DC, 20037, USA.

Archives of dermatological research

|May 25, 2024

概括

在患有阿托皮性皮肤炎 (AD) 的成年人中,疾病的严重程度和皮肤表现与喘开始时或控制得多好并不相关. 这项研究探讨了成人阿兹海默症和喘之间的联系.

科学领域:

皮肤病学和肺病学
伴发病性研究研究.
临床流行病学临床流行病学

背景情况:

喘是已知的阿托皮性皮肤炎 (AD) 的并发症.
艾滋病严重程度,形态和成人喘特征之间的具体联系仍然不清楚.
了解这些关联对于全面的患者管理至关重要.

研究的目的:

调查阿托皮性皮肤炎严重程度和形态与成人喘发病年龄和控制之间的关系.
为了澄清成年人群中这两种常见疾病之间的临床关联.
提供数据,可以为临床实践提供有关并发性AD和喘患者的信息.

主要方法:

一项涉及252名患有阿尔茨海默氏症的成年人和有喘病史的横截面研究.
通过自行管理的电子问卷收集的数据,包括AD严重程度,喘病史,发病年龄和喘控制测试 (ACT) 成绩.
用多变量逻辑回归分析来评估关联.

主要成果:

喘控制测试 (ACT) 的平均得分为21.7 (±4.3),其中21.8%的参与者报告喘控制不良 (ACT ≤19).
在阿托皮性皮炎的严重程度或形态与成人发作的喘之间没有发现显著的关联.
同样,AD的严重程度和形态与喘控制不佳没有关联.

结论:

亚托匹性皮肤炎的严重程度和形态似乎与阿兹海默症成年人的喘发病年龄或喘控制不一致.
这些发现表明,其他因素可能在成人阿兹海默症和喘特征之间的相互作用中发挥更重要的作用.
需要进一步的研究来阐明这些条件之间的复杂关系.

关键词:

喘喘是一种亚托邦性皮肤炎 (Atopic Dermatitis) 是一种不良的疾病.亚托邦 (Atopy) 是一个无形的世界.伴随性疾病伴随性疾病湿疹湿疹是一种湿疹严重程度严重程度

更多相关视频

Effects of Exposure of Formaldehyde to a Rat Model of Atopic Dermatitis Induced by Neonatal Capsaicin Treatment

Effects of Exposure of Formaldehyde to a Rat Model of Atopic Dermatitis Induced by Neonatal Capsaicin Treatment

Published on: September 27, 2017

Resolving Water, Proteins, and Lipids from In Vivo Confocal Raman Spectra of Stratum Corneum through a Chemometric Approach

Resolving Water, Proteins, and Lipids from In Vivo Confocal Raman Spectra of Stratum Corneum through a Chemometric Approach

Published on: September 26, 2019

相关概念视频

Asthma-II: Pathophysiology and Classification

Asthma-II: Pathophysiology and Classification

Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:

Asthma: Pathogenesis and Management

Asthma: Pathogenesis and Management

Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.

Asthma-I: Introduction

Asthma-I: Introduction

Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...

Asthma-III: Symptoms and Complications

Asthma-III: Symptoms and Complications

Asthma, a common chronic respiratory condition, is classified considering the frequency and severity of symptoms alongside lung function impairment. Understanding this classification is essential for appropriate treatment and management. Here's a detailed look at the classification of asthma and its clinical features and complications:
Classification of Asthma

Asthma-IV: Diagnostic and Management

Asthma-IV: Diagnostic and Management

The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:

Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs

Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs

Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...